In a crowded biotech landscape where antibiotic breakthroughs rarely break through, Peptilogics has secured a commanding $78 million in an oversubscribed Series B2 round to fuel its pivotal trial of zaloganan (PLG0206), a therapeutic candidate aimed at prosthetic joint infections (PJI). The financing was led by Presight Capital, Thiel Bio, and Founders Fund, with fresh capital from…
In a move that could reshape how software companies scale, SaaS Capital has closed a $100 million Fund V to extend its growth debt model into subscription AI applications. Rather than diluting ownership, the firm is betting on debt structures—tailored for recurring-revenue businesses—to back this emerging frontier. Debt, Not Dilution: The Logic Behind Fund V…
In an era when hospitals feel perpetually stretched, Brook.ai has quietly begun to reimagine what “care” means. The Seattle‑based healthtech startup, which melds artificial intelligence with human clinical teams, has just raised $28 million in a Series B round co‑led by UMass Memorial Health and Morningside, setting the stage for broader deployment across U.S. health…
In the evolving landscape of sales and customer service, where artificial intelligence increasingly reshapes human interactions, one startup is gaining decisive momentum. Second Nature, a dynamic AI-powered training platform, has secured $22 million in a Series B funding round, signaling strong investor confidence in its vision to revolutionize how sales and service teams prepare for…
As enterprises rush to harness the transformative potential of private LTE and 5G networks, complexity threatens to stall adoption. OneLayer, a Boston-based startup helmed by CEO and co-founder Dave Mor, is staking its claim as the essential infrastructure enabler that bridges cellular technology and enterprise IT. Closing a $28 million Series A round led by…
The insurance industry faces an unprecedented reckoning as climate change drives up the frequency and severity of natural disasters. Stand, a San Francisco-based startup, is taking a data-driven, mitigation-first approach to insuring homes exposed to catastrophic risks like wildfire, flood, and wind. Having underwritten over $1 billion in insured value in wildfire-prone California within a…
BridGene Biosciences, a San Jose–based biotech innovator focused on tackling traditionally “undruggable” molecular targets, has raised $28 million in a Series B+ funding round led by Bayland Capital. This capital injection will accelerate clinical advancement of BridGene’s lead candidate, BGC-515—a covalent TEAD inhibitor aimed at solid tumors—and fuel expansion of its proprietary IMTAC™ chemoproteomic platform…
In a bid to bridge the divide between traditional capital markets and the decentralized finance ecosystem, Temple Digital Group has secured $5 million in seed funding to develop a privacy-focused technical stack for trading digital assets on the Canton Network. Spearheaded by CEO and co-founder Evan Varsamis, the New York–based firm aims to create an…
In a market ripe for disruption, Assistive Technology Development, Inc. (ATDev) is carving a distinct path forward with its AI-driven rehabilitation and mobility solutions. The Orange, California–based startup recently closed a $3 million seed round led by Dobrzelecki Legacy Ventures, alongside contributions from Uphonest Capital, The Life Science Angels, and a consortium of industry veterans….
In an era where data is the new currency, customer research remains a stubborn bottleneck for many enterprises. The traditional process—laden with weeks of manual interviews and analysis—often leaves product teams and strategists waiting too long to act. Enter Strella, an AI-powered customer research platform that is rewriting this narrative with a bold vision: making…
